Alpha Tau Medical
Filed with the SEC on · accession 0001213900-26-120072
DRTS filed a 6-K (foreign company report) with the SEC on Nov 16, 2026. How foreign companies listed in the US report news and events — like an 8-K for them.
Alpha Tau Medical announced positive interim results from its U.S. Alpha DaRT recurrent glioblastoma trial, reporting that all treated patients are alive with median survival not reached, 100% objective response rate, and no unanticipated serious adverse events in the first six evaluable patients.
✦ Ask GOAX AI about this filing — what it means for DRTS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DRTS?
Click hereDRTS filed a 6-K (SEC filing). Alpha Tau Medical announced positive interim results from its U.S. Alpha DaRT recurrent glioblastoma trial, reporting that all treated patients are alive with median survival not reached, 100% objective response rate, and no unanticipated serious adverse events in the first six evaluable patients.
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
Get alerts when DRTS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days